{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:51:40Z","timestamp":1792803100066,"version":"4.5.0"},"reference-count":383,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ajpc.2022.100371","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T16:55:49Z","timestamp":1659804949000},"page":"100371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness"],"prefix":"10.1016","volume":"12","author":[{"given":"Michael E.","family":"Makover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5810-5460","authenticated-orcid":false,"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2022.100371_bib0001","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","article-title":"Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study","volume":"8","author":"Song","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajpc.2022.100371_bib0002","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0003","unstructured":"Jr. MLk. Beyond Vietnam: A Time to Break the Silence. Addressing a crowd of 3,000 at Riverside Church in New York City. 1967."},{"key":"10.1016\/j.ajpc.2022.100371_bib0004","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCRESAHA.116.309115","article-title":"Decline in cardiovascular mortality: possible causes and Implications","volume":"120","author":"Mensah","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1146\/annurev-publhealth-031210-101211","article-title":"Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care","volume":"32","author":"Ford","year":"2011","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.ajpc.2022.100371_bib0006","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.amjmed.2014.04.015","article-title":"The epidemic of the 20(th) century: coronary heart disease","volume":"127","author":"Dalen","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0007","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0008","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.1920391117","article-title":"US life expectancy stalls due to cardiovascular disease, not drug deaths","volume":"117","author":"Mehta","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.ajpc.2022.100371_bib0009","article-title":"Quality of life after myocardial infarction: more progress needed","volume":"106","author":"Doll","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2022.100371_bib0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/HCO.0000000000000458","article-title":"Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us?","volume":"32","author":"Kulik","year":"2017","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0011","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/jgs.16329","article-title":"Failure of traditional risk factors to adequately predict cardiovascular events in older populations","volume":"68","author":"Dalton","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ajpc.2022.100371_bib0012","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jacl.2021.12.001","article-title":"Guideline based eligibility for primary prevention statin therapy - Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI)","volume":"16","author":"Arora","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2017.11.007","article-title":"Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry","volume":"71","author":"Singh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005333","article-title":"Statin eligibility and outpatient care prior to ST-segment elevation myocardial infarction","volume":"6","author":"Miedema","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100371_bib0015","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.114.014310","article-title":"Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (progression of early subclinical atherosclerosis) study","volume":"131","author":"Fern\u00e1ndez-Friera","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0016","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2020.02.026","article-title":"Short-term progression of multiterritorial subclinical atherosclerosis","volume":"75","author":"L\u00f3pez-Melgar","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0017","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1161\/STROKEAHA.111.648667","article-title":"Intracranial carotid artery atherosclerosis","volume":"43","author":"Bos","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ajpc.2022.100371_bib0018","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ajpc.2022.100371_bib0019","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/geront\/37.2.150","article-title":"Aging and Alzheimer's disease: lessons from the nun study","volume":"37","author":"Snowdon","year":"1997","journal-title":"Gerontologist"},{"key":"10.1016\/j.ajpc.2022.100371_bib0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ebiom.2019.07.007","article-title":"Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: a Mendelian randomization study in UK biobank","volume":"45","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ajpc.2022.100371_bib0021","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/eurheartj\/ehu197","article-title":"Importance of frailty in patients with cardiovascular disease","volume":"35","author":"Singh","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0022","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrd1112","article-title":"Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors","volume":"2","author":"Tobert","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100371_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2165\/00003495-198800363-00021","article-title":"The US national cholesterol education program. Adult treatment guidelines","volume":"36","author":"Hulley","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.ajpc.2022.100371_bib0024","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archinte.1988.00380010040006","article-title":"Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. The expert panel","volume":"148","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0025","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCULATIONAHA.119.044562","article-title":"Comparing primary prevention recommendations","volume":"141","author":"Stone","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0026","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12872-020-01697-6","article-title":"Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study","volume":"20","author":"Yebyo","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100371_bib0027","doi-asserted-by":"crossref","DOI":"10.1007\/s12170-019-0597-x","article-title":"Worldwide dyslipidemia guidelines","volume":"13","author":"Bartlomiejczyk","year":"2019","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0028","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.atherosclerosissup.2021.01.001","article-title":"Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk","volume":"42","author":"Tokg\u00f6zo\u011flu","year":"2020","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.ajpc.2022.100371_bib0029","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacl.2021.04.001","article-title":"Clinical reasoning and prevention of cardiovascular disease","volume":"15","author":"Allan","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0030","unstructured":"Tufekci Z. Why did it take so long to accept the facts about COVID? New York Times 7 May 2021."},{"key":"10.1016\/j.ajpc.2022.100371_bib0031","article-title":"Low-density lipoprotein cholesterol treatment rates in high risk patients: more disappointment despite ever more refined evidence-based guidelines","volume":"6","author":"Toth","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0032","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.amjcard.2019.04.017","article-title":"Adherence to blood cholesterol treatment guidelines among physicians managing patients with atherosclerotic cardiovascular disease","volume":"124","author":"Ramsaran","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0033","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3803\/EnM.2020.35.2.367","article-title":"Achievement of LDL-C targets defined by ESC\/EAS (2011) guidelines in risk-stratified Korean patients with dyslipidemia receiving lipid-modifying treatments","volume":"35","author":"Yang","year":"2020","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0034","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacl.2019.05.004","article-title":"Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: the international cholesterol management practice study","volume":"13","author":"Blom","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12944-019-1099-z","article-title":"Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis","volume":"18","author":"Toth","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0036","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/M17-1566","article-title":"Statin Denial: an internet-driven cult with deadly consequences","volume":"167","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0037","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13186","article-title":"Cardiovascular outcomes and mortality associated with discontinuing statins in older patients receiving polypharmacy","volume":"4","author":"Rea","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2022.100371_bib0038","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2016.12.036","article-title":"Statin intolerance and risk of coronary heart events and all-cause mortality following myocardial infarction","volume":"69","author":"Serban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0039","first-page":"40","article-title":"Effect of passive choice and active choice interventions in the electronic health record to cardiologists on statin prescribing: a cluster randomized clinical trial","volume":"6","author":"Adusumalli","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0040","volume":"6","author":"Baum","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0041","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacl.2016.01.002","article-title":"The very high residual degree of death and disease from atherosclerosis needs new approaches","volume":"10","author":"Makover","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0042","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/VHRM.S37119","article-title":"Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes","volume":"9","author":"Kones","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ajpc.2022.100371_bib0043","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1253\/circj.CJ-19-0624","article-title":"Strategies to overcome residual risk during statins era","volume":"83","author":"Cho","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(97)00161-5","article-title":"Nikolaj Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research","volume":"135","author":"Finking","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0045","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1194\/jlr.R400003-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I","volume":"45","author":"Steinberg","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0046","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1194\/jlr.R800054-JLR200","article-title":"Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL","volume":"50","author":"Brown","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0047","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.115.306246","article-title":"Microdomains, inflammation, and atherosclerosis","volume":"118","author":"Sorci-Thomas","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0048","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0049","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.121.315579","article-title":"Profiling of primary and mature miRNA expression in atherosclerosis associated cell types","author":"Moreau","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0050","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.P120001000","article-title":"Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study","volume":"62","author":"Thomas","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100064","article-title":"Genetic evidence for independent causal relationships between metabolic biomarkers and risk of coronary artery diseases","volume":"62","author":"Allayee","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0052","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCRESAHA.115.306297","article-title":"The success story of LDL cholesterol lowering","volume":"118","author":"Pedersen","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0053","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41569-021-00511-w","article-title":"Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases","volume":"18","author":"Ren","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1388-1981(00)00123-2","article-title":"Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL","volume":"1488","author":"Hevonoja","year":"2000","journal-title":"Biochim Biophys Acta BBA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0056","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.arcmed.2015.05.010","article-title":"Nutrition and atherosclerosis","volume":"46","author":"Torres","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0057","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2020.5685","article-title":"Lipids and lipoproteins in 2020","volume":"324","author":"Ference","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.674103","article-title":"Pathological crosstalk between oxidized LDL and ER stress in human diseases: a comprehensive review","volume":"9","author":"Varghese","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0059","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S0066-782X2006000600003","article-title":"Concentration of serum lipids and apolipoprotein B in newborns","volume":"86","author":"Doneg\u00e1","year":"2006","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0062","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12291-012-0252-5","article-title":"Correlation of cord blood lipid heterogeneity in neonates with their anthropometry at birth","volume":"28","author":"Nayak","year":"2013","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.ajpc.2022.100371_bib0063","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1542\/peds.53.4.458","article-title":"Cholesterol at Birth and Age 1: comparison of normal and hypercholesterolemic neonates","volume":"53","author":"Tsang","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpc.2022.100371_bib0064","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.mol.0000174154.61307.16","article-title":"Cord blood lipoproteins and prenatal influences","volume":"16","author":"Bansal","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0067","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0068","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/obr.12785","article-title":"Hunter-gatherers as models in public health","volume":"19","author":"Pontzer","year":"2018","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajpc.2022.100371_bib0069","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jacc.2004.03.046","article-title":"Optimal low-density lipoprotein is 50 to 70mg\/dl: lower is better and physiologically normal","volume":"43","author":"O'Keefe","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(99)80474-3","article-title":"Range of serum cholesterol values in the population developing coronary artery disease","volume":"76","author":"Kannel","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0071","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.118.034273","article-title":"Long-term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease","volume":"138","author":"Abdullah","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0072","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2020.08.004","article-title":"Cholesterol-years\u201d for ASCVD risk prediction and treatment\u2217","volume":"76","author":"Shapiro","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0073","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/jama.2014.2632","article-title":"Comparison of application of the ACC\/AHA guidelines, adult treatment panel III guidelines, and European society of cardiology guidelines for cardiovascular disease prevention in a European cohort","volume":"311","author":"Kavousi","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0074","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.mayocp.2013.07.012","article-title":"The necessity for clinical reasoning in the era of evidence-based medicine","volume":"88","author":"Sniderman","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajpc.2022.100371_bib0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jama.2015.6177","article-title":"The role of physicians in the era of predictive analytics","volume":"314","author":"Sniderman","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0076","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1353\/pbm.2002.0070","article-title":"Evidence-based medicine, opinion-based medicine, and real-world medicine","volume":"45","author":"Hampton","year":"2002","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacl.2017.02.011","article-title":"From the editor: new guidelines are coming","volume":"11","author":"Brown","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0078","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.174194","article-title":"Receptor-mediated control of cholesterol metabolism","volume":"191","author":"Brown","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ajpc.2022.100371_bib0079","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/138920208783884856","article-title":"Genetic variation and atherosclerosis","volume":"9","author":"Biros","year":"2008","journal-title":"Curr Genomics"},{"key":"10.1016\/j.ajpc.2022.100371_bib0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCRESAHA.115.306464","article-title":"From loci to biology: functional genomics of genome-wide association for coronary disease","volume":"118","author":"Nurnberg","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0081","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0082","article-title":"Inflammation and cardiovascular disease: from mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0083","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7015-12-47","article-title":"Is atherosclerosis an autoimmune disease?","volume":"12","author":"Matsuura","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0084","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0085","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0086","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2018.01.021","article-title":"Inflammation and atherosclerosis: cardiovascular evaluation in patients with autoimmune diseases","volume":"17","author":"Esc\u00e1rcega","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajpc.2022.100371_bib0087","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/2047487319869400","article-title":"Lifestyle factors and high-risk atherosclerosis: pathways and mechanisms beyond traditional risk factors","volume":"27","author":"Lechner","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0088","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1559827618812395","article-title":"Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease","volume":"13","author":"Rippe","year":"2019","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0089","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/ATVBAHA.120.315219","article-title":"Ambient air pollution and atherosclerosis: insights into dose, time, and mechanisms","volume":"41","author":"Bevan","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.12997\/jla.2020.9.3.334","article-title":"Are persistent organic pollutants linked to lipid abnormalities, atherosclerosis and cardiovascular disease? A review","volume":"9","author":"Lind","year":"2020","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.ajpc.2022.100371_bib0091","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/emmm.201000063","article-title":"A systems biology approach to understanding atherosclerosis","volume":"2","author":"Ramsey","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0092","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tcm.2019.02.004","article-title":"Statin therapy for young adults: a long-term investment worth considering","volume":"30","author":"Miedema","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0093","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCULATIONAHA.118.039107","article-title":"Inhibition of angiopoietin-like protein 3 with a monoclonal antibody reduces triglycerides in hypertriglyceridemia","volume":"140","author":"Ahmad","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0094","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in atherosclerosis-no longer a theory","volume":"67","author":"Libby","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpc.2022.100371_bib0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/ATVBAHA.118.310958","article-title":"Novel antiatherosclerotic therapies","volume":"39","author":"Libby","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0096","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0097","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.arcmed.2015.06.004","article-title":"Reality of a vaccine in the prevention and treatment of atherosclerosis","volume":"46","author":"Garc\u00eda-Gonz\u00e1lez","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0099","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJM198601163140302","article-title":"Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa heart study","volume":"314","author":"Newman","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0100","first-page":"209","article-title":"The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the of the 20th century","volume":"34","author":"Holman","year":"1958","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0021-9150(87)90234-6","article-title":"Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children","volume":"64","author":"Stary","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0102","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2786","article-title":"Dietary fats and atherosclerosis from childhood to adulthood","volume":"145","author":"Laitinen","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpc.2022.100371_bib0103","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jama.281.8.727","article-title":"Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study","volume":"281","author":"Strong","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0104","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016115","article-title":"Challenges and opportunities for the prevention and treatment of cardiovascular disease among young adults: report from a national heart, lung, and blood institute working group","volume":"9","author":"Gooding","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100371_bib0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/CIRCULATIONAHA.115.018042","article-title":"Pathobiological determinants of atherosclerosis in youth (PDAY) risk score in young adults predicts coronary artery and abdominal aorta calcium in middle age","volume":"133","author":"Gidding","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0106","first-page":"11","article-title":"DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses","author":"Chiavaroli","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpc.2022.100371_bib0107","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease","volume":"131","author":"Navar-Boggan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0108","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacl.2020.12.003","article-title":"The impact of dyslipidemia on early markers of endothelial and renal dysfunction in children","volume":"15","author":"Kosmeri","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0109","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5551\/jat.48603","article-title":"The goal of achieving atherosclerotic plaque regression with lipid-lowering therapy: insights from IVUS trials","volume":"26","author":"Daida","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ajpc.2022.100371_bib0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/ATVBAHA.115.301926","article-title":"Regression of atherosclerosis","volume":"36","author":"Fisher","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0111","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12170-015-0442-9","article-title":"The early life origins of cardiovascular disease","volume":"9","author":"Murray","year":"2015","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0112","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the cardiovascular risk in young finns study","volume":"290","author":"Raitakari","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/ATVBAHA.118.311366","article-title":"Cholesterol mass efflux capacity, incident cardiovascular disease, and progression of carotid plaque","volume":"39","author":"Shea","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0114","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0066-782X2002000100014","article-title":"Anatomicopathological evidence of the beginning of atherosclerosis in infancy and adolescence","volume":"78","author":"Fran\u00e7oso","year":"2002","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0735-1097(93)90050-B","article-title":"Manifestations of coronary atherosclerosis in young trauma victims \u2013 an autopsy study","volume":"22","author":"Joseph","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0116","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1001\/jama.1986.03380200101029","article-title":"Coronary Atherosclerosis in soldiers: a clue to the natural history of atherosclerosis in the young","volume":"256","author":"Strong","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0117","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11883-012-0296-2","article-title":"The rationale for initiating treatment of hypercholesterolemia in young adulthood","volume":"15","author":"Steinberg","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0118","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa2109191","article-title":"Childhood cardiovascular risk factors and adult cardiovascular events","volume":"386","author":"Jacobs","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0119","article-title":"Caring for US children: barriers to effective treatment in children with the disease of obesity","volume":"29","author":"Srivastava","year":"2021","journal-title":"Obes"},{"key":"10.1016\/j.ajpc.2022.100371_bib0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/oby.22987","article-title":"Caring for US children: barriers to effective treatment in children with the disease of obesity","volume":"29","author":"Srivastava","year":"2021","journal-title":"Obesity"},{"key":"10.1016\/j.ajpc.2022.100371_bib0121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0122","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0123","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0140-6736(17)30752-3","article-title":"Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study","volume":"389","author":"Kaplan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0124","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0140-6736(17)30752-3","article-title":"Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study","volume":"389","author":"Kaplan","year":"2017","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ajpc.2022.100371_bib0125","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jacc.2007.05.055","article-title":"Time to end the mixed\u2014and often incorrect\u2014messages about prevention and treatment of atherosclerotic cardiovascular disease","volume":"50","author":"Greenland","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0126","first-page":"1","article-title":"Prevalence of uncontrolled risk factors for cardiovascular disease: united States, 1999-2010","author":"Fryar","year":"2012","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajpc.2022.100371_bib0127","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/dc06-0310","article-title":"Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes","volume":"29","author":"Rodriguez","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2022.100371_bib0128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-physiol-021317-121550","article-title":"SR-B1: a unique multifunctional receptor for cholesterol influx and efflux","volume":"80","author":"Shen","year":"2018","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-7075-7-47","article-title":"Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones","volume":"7","author":"Hu","year":"2010","journal-title":"Nutr Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacl.2017.12.018","article-title":"Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels \u2013 the zero-LDL hypothesis","volume":"12","author":"Masana","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2018.04.021","article-title":"The prevalence and correlates of subclinical atherosclerosis among adults with low-density lipoprotein cholesterol <70\u00a0mg\/dL: the multi-ethnic study of atherosclerosis (MESA) and Brazilian longitudinal study of adult health (ELSA-Brasil)","volume":"274","author":"Al Rifai","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0132","article-title":"Apolipoproteins in vascular biology and atherosclerotic disease","author":"Mehta","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0133","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0134","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini","year":"2018","journal-title":"Clin Sci"},{"key":"10.1016\/j.ajpc.2022.100371_bib0135","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0136","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ncpcardio1086","article-title":"Rapid regression of atherosclerosis: insights from the clinical and experimental literature","volume":"5","author":"Williams","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0137","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Bor\u00e9n","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0138","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/CS20110449","article-title":"The causal exposure model of vascular disease","volume":"122","author":"Sniderman","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.ajpc.2022.100371_bib0139","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100371_bib0140","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1038\/sj.ijo.0802498","article-title":"Macrophages, inflammation, and atherosclerosis","volume":"27","author":"Linton","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ajpc.2022.100371_bib0142","series-title":"Endotext","article-title":"The role of lipids and lipoproteins in atherosclerosis","author":"Linton","year":"2000"},{"key":"10.1016\/j.ajpc.2022.100371_bib0143","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-4580(00)00119-6","article-title":"Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease","volume":"21","author":"Shi","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpc.2022.100371_bib0144","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2318-14-36","article-title":"Atherosclerosis and Alzheimer-diseases with a common cause? Inflammation, oxysterols, vasculature","volume":"14","author":"Lathe","year":"2014","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.ajpc.2022.100371_bib0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.22055","article-title":"Atherosclerosis, dementia, and Alzheimer disease in the Baltimore longitudinal study of aging cohort","volume":"68","author":"Dolan","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0146","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-4580(00)00125-1","article-title":"The role of cerebral ischemia in Alzheimer's disease","volume":"21","author":"Kalaria","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpc.2022.100371_bib0147","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jacc.2020.12.027","article-title":"Subclinical atherosclerosis and brain metabolism in middle-aged individuals","volume":"77","author":"Cortes-Canteli","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0148","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41593-020-0626-6","article-title":"Revisiting atherosclerosis and dementia","volume":"23","author":"Iadecola","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ajpc.2022.100371_bib0149","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCRESAHA.118.313400","article-title":"Cerebrovascular alterations in Alzheimer Disease","volume":"123","author":"Iadecola","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0150","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100371_bib0151","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.injury.2010.03.033","article-title":"Challenging issues in randomised controlled trials","volume":"41","author":"Nichol","year":"2010","journal-title":"Injury"},{"key":"10.1016\/j.ajpc.2022.100371_bib0152","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archneurol.2011.203","article-title":"Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0153","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamaneurol.2019.0648","article-title":"Association of Early-onset Alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic Coding variants of APOB","volume":"76","author":"Wingo","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0154","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacl.2020.12.011","article-title":"Statins, lipids and dementia?","volume":"15","author":"Kuller","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/bcp.13202","article-title":"Statins and mortality: the untold story","volume":"83","author":"Kostapanos","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0156","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0157","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/er.2018-00141","article-title":"Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents","volume":"40","author":"Di Pino","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajpc.2022.100371_bib0158","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0159","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12170-017-0537-6","article-title":"Novel immune mechanisms in hypertension and cardiovascular risk","volume":"11","author":"Nosalski","year":"2017","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0160","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0002-9149(76)90357-X","article-title":"Role of hypertension in atherosclerosis and cardiovascular disease","volume":"38","author":"Hollander","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0161","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","article-title":"The different facets of dyslipidemia and hypertension in atherosclerosis","volume":"18","author":"Hurtubise","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0162","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.2174\/092986732134141015161539","article-title":"Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches","volume":"21","author":"Siasos","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ajpc.2022.100371_bib0163","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/ATVBAHA.114.304960","article-title":"Relationship of cigarette smoking with inflammation and subclinical vascular disease: the multi-ethnic study of atherosclerosis","volume":"35","author":"McEvoy","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0164","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/eurheartj\/ehy119","article-title":"Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis","volume":"39","author":"Dragoljevic","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0166","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tem.2020.02.005","article-title":"Interplay between clonal hematopoiesis of indeterminate potential and metabolism","volume":"31","author":"Lee","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0167","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030094","article-title":"Clonal hematopoiesis of indeterminate potential: a multidisciplinary challenge in personalized hematology","volume":"10","author":"Hoermann","year":"2020","journal-title":"J Pers Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0168","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-021-00554-z","article-title":"Clonal haematopoiesis and atherosclerosis: a chicken or egg question?","volume":"18","author":"S\u00e1nchez-Cabo","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0169","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(20)30114-8","article-title":"Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000\u201317: analysis for the global burden of disease study 2017","volume":"395","author":"Reiner","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ajpc.2022.100371_bib0170","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.119.312463","article-title":"Neutrophil Extracellular Traps","volume":"39","author":"Th\u00e5lin","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0171","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134796","article-title":"Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice","volume":"5","author":"Josefs","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpc.2022.100371_bib0172","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2019.06.919","article-title":"The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis","volume":"288","author":"Moschonas","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0173","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1289\/ehp.1103563","article-title":"Circulating levels of persistent organic pollutants (POPs) and carotid atherosclerosis in the elderly","volume":"120","author":"Lind","year":"2012","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ajpc.2022.100371_bib0174","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.tem.2019.08.008","article-title":"NAFLD and atherosclerosis: two sides of the same dysmetabolic coin?","volume":"30","author":"Stols-Gon\u00e7alves","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0175","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/dom.13537","article-title":"Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol","volume":"21","author":"Nichols","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0176","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0177","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1273042","article-title":"Small dense low-density lipoprotein as biomarker for atherosclerotic diseases","volume":"2017","author":"Ivanova","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ajpc.2022.100371_bib0178","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C\u2013lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0179","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.105.567107","article-title":"Increased small low-density lipoprotein particle number","volume":"113","author":"Kathiresan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0180","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1463-1326.2005.00478.x","article-title":"Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes","volume":"7","author":"Woodman","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0181","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/qjmed\/hcl027","article-title":"Apolipoproteins as markers and managers of coronary risk","volume":"99","author":"Chan","year":"2006","journal-title":"QJM Int J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0182","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0183","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/joim.12614","article-title":"Can LDL cholesterol be too low? Possible risks of extremely low levels","volume":"281","author":"Olsson","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0184","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa1080","article-title":"How low is safe? The frontier of very low (<30mg\/dL) LDL cholesterol","author":"Karagiannis","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0185","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0186","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0187","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamacardio.2018.2258","article-title":"Efficacy and safety of further lowering of low-density lipoprotein cholesterol in patients starting with very low levels: a meta-analysis","volume":"3","author":"Sabatine","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0188","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjcard.2005.11.014","article-title":"Justification for the use of statins in primary prevention: an intervention trial evaluating rosuvastatin (JUPITER)\u2014can C-reactive protein be used to target statin therapy in primary prevention?","volume":"97","author":"Mora","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0189","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0190","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0191","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0192","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0194","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.jacc.2020.03.039","article-title":"Cognition after lowering LDL-cholesterol with evolocumab","volume":"75","author":"Gencer","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0195","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease","volume":"60","author":"Ference","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0196","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11886-017-0858-6","article-title":"Targeting LDL cholesterol: beyond absolute goals toward personalized risk","volume":"19","author":"Leibowitz","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0197","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0198","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(18)32818-6","article-title":"Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial","volume":"393","author":"N\u00e4slund","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0199","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ajh\/hpy068","article-title":"Apheresis to mitigate atherosclerotic vascular disease","volume":"31","author":"Sachais","year":"2018","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajpc.2022.100371_bib0200","doi-asserted-by":"crossref","first-page":"e14400","DOI":"10.1097\/MD.0000000000014400","article-title":"Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: a frequentist network meta-analysis","volume":"98","author":"Zhao","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ajpc.2022.100371_bib0201","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2014.03.003","article-title":"NLA task force on statin safety-2014 update","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/07853890701214881","article-title":"The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions","volume":"39","author":"May","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0203","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol\u2013lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0204","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.1125884","article-title":"Lowering LDL-not only how low, but how long?","volume":"311","author":"Brown","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajpc.2022.100371_bib0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.272.5262.629","article-title":"Heart attacks: gone with the century?","volume":"272","author":"Brown","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ajpc.2022.100371_bib0206","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/ATVBAHA.115.301926","article-title":"Regression of atherosclerosis: the journey from the liver to the plaque and back","volume":"36","author":"Fisher","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0207","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","article-title":"Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis","volume":"297","author":"Nicholls","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0208","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosisa randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0209","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0210","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0211","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/cvr\/cvaa085","volume":"117","author":"Alexander","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0213","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajpath.2017.01.018","article-title":"Boosting inflammation resolution in atherosclerosis: the next frontier for therapy","volume":"187","author":"Fredman","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0214","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2020.08.004","article-title":"Cholesterol-years\u201d for ASCVD risk prediction and treatment\u2217","volume":"76","author":"Shapiro Michael","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0215","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","article-title":"PCSK9: a convertase that coordinates LDL catabolism","volume":"50","author":"Horton","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0216","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0217","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0218","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/heartjnl-2020-318760","article-title":"Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges","volume":"107","author":"Packard","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2022.100371_bib0219","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.jacc.2012.09.016","article-title":"The case for treating hypercholesterolemia at an earlier age","volume":"60","author":"Steinberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0220","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.327.7429.1459","article-title":"Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials","volume":"327","author":"Smith","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajpc.2022.100371_bib0222","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2014.02.615","article-title":"Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials","volume":"64","author":"Boekholdt","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0223","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the Fourier trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ajpc.2022.100371_bib0224","article-title":"Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960\u20131962 through 2017\u20132018","author":"Fryar","year":"2020","journal-title":"NCHS Health E-Stats"},{"key":"10.1016\/j.ajpc.2022.100371_bib0225","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.15585\/mmwr.mm6845a2","article-title":"Tobacco product use and cessation indicators among adults - United States, 2018","volume":"68","author":"Creamer","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0226","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","article-title":"The national lipid association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction","volume":"15","author":"Orringer","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0227","first-page":"420","article-title":"Atherosclerotic plaque in patients with zero calcium score at coronary computed tomography angiography","volume":"110","author":"Gabriel","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0228","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000945","article-title":"A zero coronary artery calcium score in patients with stable chest pain is associated with a good prognosis, despite risk of non-calcified plaques","volume":"6","author":"Wang","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.ajpc.2022.100371_bib0229","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0230","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2967\/jnumed.119.230276","article-title":"Vascular calcification: the evolving relationship of vascular calcification to major acute coronary events","volume":"60","author":"Strauss","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0231","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2214\/AJR.08.1277","article-title":"Noncalcified atherosclerotic plaque burden at coronary CT angiography: a better predictor of ischemia at stress myocardial perfusion imaging than calcium score and stenosis severity","volume":"193","author":"Bauer","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0232","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0233","first-page":"734","article-title":"The case against coronary artery calcium scoring for cardiovascular disease risk assessment","volume":"100","author":"Mandrola","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajpc.2022.100371_bib0234","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mayocp.2019.05.001","article-title":"Acute myocardial infarction in young individuals","volume":"95","author":"Gulati","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajpc.2022.100371_bib0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/pgmj.2004.027532","article-title":"Myocardial infarction in young adults","volume":"81","author":"Egred","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0236","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/HCO.0000000000000781","article-title":"Recent trends in acute myocardial infarction among the young","volume":"35","author":"Wu","year":"2020","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0237","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1701131","article-title":"Cognitive function in a randomized trial of evolocumab","volume":"377","author":"Giugliano","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0238","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.119.043826","article-title":"Effect of alirocumab on stroke in odyssey outcomes","volume":"140","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0239","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12170-015-0444-7","article-title":"Statins and incident diabetes: can risk outweigh benefit?","volume":"9","author":"Florido","year":"2015","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0240","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14740338.2019.1620730","article-title":"Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data","volume":"18","author":"Strilchuk","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ajpc.2022.100371_bib0241","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0243","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinte.163.3.333","article-title":"The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?","volume":"163","author":"Grover","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0244","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.37765\/ajmc.2020.88482","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ajpc.2022.100371_bib0245","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1573403X11666141122220003","article-title":"Disparities in cardiovascular disease risk in the United States","volume":"11","author":"Graham","year":"2015","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.ajpc.2022.100371_bib0246","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12944-016-0302-8","article-title":"Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center","volume":"15","author":"Shah","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.05.007","article-title":"Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?","volume":"304","author":"Ademi","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0249","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamacardio.2019.2851","article-title":"Cost-effectiveness of low-density lipoprotein cholesterol level\u2013guided statin treatment in patients with borderline cardiovascular risk","volume":"4","author":"Kohli-Lynch","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0250","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2021.08.072","article-title":"Time to Relax the 40-year age threshold for pharmacologic cholesterol lowering*","volume":"78","author":"Heidenreich","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0251","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.6822","article-title":"Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease","volume":"314","author":"Pandya","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100371_bib0252","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIRCULATIONAHA.110.986349","article-title":"Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era","volume":"124","author":"Lazar","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0253","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCULATIONAHA.117.027067","article-title":"Evaluating the impact and cost-effectiveness of statin use guidelines for primary prevention of coronary heart disease and stroke","volume":"136","author":"Heller","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0254","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1038\/s41598-021-87528-w","article-title":"The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0255","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0256","article-title":"Intensive lipid lowering agents and coronary atherosclerosis: insights from intravascular imaging","volume":"11","author":"Di Giovanni","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0257","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0735-1097(22)02463-9","article-title":"Efficacy and safety of early lipid lowering treatment in children with familial hypercholesterolemia","volume":"79","author":"Juliani","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0258","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0259","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0735-1097(22)02463-9","article-title":"Efficacy and safety of early lipid lowering treatment in children with familial hypercholesterolemia","volume":"79","author":"Juliani Fabiana","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0261","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11883-014-0409-1","article-title":"\"sick fat,\" Ockham's razor, and resolution of the obesity paradox","volume":"16","author":"Adiposopathy","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0262","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacl.2021.01.012","article-title":"Utility of metabolic syndrome as a risk enhancing factor in decision of statin use","volume":"15","author":"Vega","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0263","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.jacc.2021.03.335","article-title":"Glycated hemoglobin and subclinical atherosclerosis in people without diabetes","volume":"77","author":"Rossello","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0264","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2022.100371_bib0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40292-018-0290-z","article-title":"Hypertension management at older age: an update","volume":"26","author":"Del Pinto","year":"2019","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.ajpc.2022.100371_bib0266","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.amjmed.2018.06.007","article-title":"When guidelines cause hypertension","volume":"131","author":"Wald","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0267","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-2252","article-title":"Associations of systolic blood pressure and diastolic blood pressure with the incidence of coronary artery disease or cerebrovascular disease according to glucose status","author":"Yamada","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2022.100371_bib0268","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a)","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0269","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4068\/cmj.2021.57.1.36","article-title":"Recent updates of lipoprotein(a) and cardiovascular disease","volume":"57","author":"Liu","year":"2021","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0270","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dc19-1398","article-title":"The association of lipozprotein(a) plasma levels with prevalence of cardiovascular disease and metabolic control status in patients with type 1 diabetes","volume":"43","author":"Littmann","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2022.100371_bib0271","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0272","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jacl.2015.07.006","article-title":"Lipoprotein(a): its relevance to the pediatric population","volume":"9","author":"McNeal","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0273","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2012.02.008","article-title":"Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis","volume":"222","author":"Momiyama","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0274","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12170-017-0553-6","article-title":"Lp(a) in childhood","volume":"11","author":"Prendergast","year":"2017","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0275","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0276","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HCO.0000000000000842","article-title":"Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology","volume":"36","author":"Page","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0277","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tips.2019.01.004","article-title":"New frontiers in Lp(a)-targeted therapies","volume":"40","author":"Borrelli","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ajpc.2022.100371_bib0278","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/eurheartj\/ehaa552","article-title":"The next chapter of prevention: from LDL-cholesterol to lipoprotein(a) and triglycerides","volume":"41","author":"L\u00fcscher","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0279","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/1076029609334124","article-title":"Lipoprotein (a) levels in childhood arterial ischemic stroke","volume":"16","author":"Teber","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ajpc.2022.100371_bib0281","article-title":"Management of familial hypercholesterolemia: current status and future perspectives","volume":"5","author":"Lui","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ajpc.2022.100371_bib0282","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0283","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0284","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12967-017-1321-6","article-title":"GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk","volume":"15","author":"Connelly","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0285","doi-asserted-by":"crossref","DOI":"10.21037\/jlpm.2020.03.03","article-title":"GlycA: a new biomarker for systemic inflammation and cardiovascular disease (CVD) risk assessment","volume":"5","author":"Ballout","year":"2020","journal-title":"J Lab Precis Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0286","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0003319719845185","article-title":"GlycA, a novel inflammatory marker and its association with peripheral arterial disease and carotid plaque: the multi-ethnic study of atherosclerosis","volume":"70","author":"Fashanu","year":"2019","journal-title":"Angiology"},{"key":"10.1016\/j.ajpc.2022.100371_bib0287","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0288","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10557-021-07168-0","article-title":"Genetics of triglyceride-rich lipoproteins guide identification of pharmacotherapy for cardiovascular risk reduction","volume":"35","author":"Shaik","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ajpc.2022.100371_bib0289","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/VHRM.S104369","article-title":"Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease","volume":"12","author":"Toth","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ajpc.2022.100371_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2021.03.007","article-title":"Prevention of atherosclerotic cardiovascular disease in South Asians in the US: a clinical perspective from the national lipid association","author":"Kalra","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0291","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2021.04.004","article-title":"Lower triglyceride levels are associated with better endothelial function","author":"Takaeko","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0292","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S2213-8587(19)30388-2","article-title":"Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327\u2008037 participants","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0293","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/eurheartj\/ehx741","article-title":"Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C","volume":"39","author":"Davidson","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0294","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/eurheartj\/ehz809","article-title":"Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an odyssey outcomes trial analysis","volume":"41","author":"Sinnaeve","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0295","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.117.028271","article-title":"Primary prevention with statin therapy in the elderly: new meta-analyses from the contemporary Jupiter and Hope-3 randomized trials","volume":"135","author":"Ridker","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0296","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(20)32333-3","article-title":"Never too old to benefit from lipid-lowering treatment","volume":"396","author":"Raal","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ajpc.2022.100371_bib0297","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(20)32332-1","article-title":"Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials","volume":"396","author":"Gencer","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ajpc.2022.100371_bib0298","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","article-title":"Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: a contemporary primary prevention cohort","volume":"396","author":"Mortensen","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ajpc.2022.100371_bib0299","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2021.05.022","article-title":"Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: a propensity-matched cohort study","volume":"328","author":"Cho","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0301","first-page":"166","article-title":"Autonomic and Vascular control in prehypertensive subjects with a family history of arterial hypertension","volume":"110","author":"Amaral","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0302","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9149(79)90251-0","article-title":"Familial occurrence of coronary heart disease: effect of age at diagnosis","volume":"44","author":"Rissanen","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0303","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001648-200103000-00014","article-title":"Family history of coronary heart disease, a strong risk factor for myocardial infarction interacting with other cardiovascular risk factors: results from the Stockholm heart epidemiology program (SHEEP)","volume":"12","author":"Leander","year":"2001","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajpc.2022.100371_bib0304","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2013.07.059","article-title":"Family history of coronary heart disease as a predictor of the incidence and progression of coronary artery calcification","volume":"233","author":"Panagiotakos","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0305","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2013.11.042","article-title":"Family history of coronary heart disease and the incidence and progression of coronary artery calcification: multi-ethnic study of atherosclerosis (MESA)","volume":"232","author":"Pandey","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0306","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.diabet.2015.09.004","article-title":"Family history of diabetes and the risk of subclinical atherosclerosis","volume":"42","author":"Park","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0307","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/jhh.2009.26","article-title":"Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals","volume":"23","author":"Solini","year":"2009","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ajpc.2022.100371_bib0308","first-page":"2613","article-title":"Association of metabolically healthy obesity with subclinical coronary atherosclerosis in a Korean population","volume":"22","author":"Jung","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.ajpc.2022.100371_bib0309","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11883-017-0671-0","article-title":"Is obesity the new hypertension? Parallels in the evolution of obesity and hypertension as recognized disease states","volume":"19","author":"Umashanker","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0310","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","article-title":"Obesity, adiposity, and dyslipidemia: a consensus statement from the national lipid association","volume":"7","author":"Bays","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0311","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0312","article-title":"Multifaceted physiological roles of adiponectin in inflammation and diseases","volume":"21","author":"Choi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2022.100371_bib0313","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5551\/jat.ED146","article-title":"Chronic kidney disease and atherosclerosis: an important implication of carotid intima-media thickness","volume":"28","author":"Ohtake","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ajpc.2022.100371_bib0314","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2215\/CJN.11951115","article-title":"Carotid intima-media thickness and incident ESRD: the atherosclerosis risk in communities (ARIC) study","volume":"11","author":"Pang","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","article-title":"Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches","volume":"99","author":"D\u00fcsing","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ajpc.2022.100371_bib0316","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arcmed.2015.05.009","article-title":"Residual cardiovascular risk in chronic kidney disease: role of high-density lipoprotein","volume":"46","author":"Kon","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0317","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.117.311603","article-title":"Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality","volume":"121","author":"Bano","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0318","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hlc.2020.11.010","article-title":"The role of colchicine in atherosclerotic cardiovascular disease","volume":"30","author":"Kurup","year":"2021","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ajpc.2022.100371_bib0319","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pcad.2008.03.001","article-title":"Obstructive sleep apnea and atherosclerosis","volume":"51","author":"L\u00e9vy","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0320","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1165\/rcmb.2017-0253ED","article-title":"Obstructive sleep apnea and atherosclerosis: both the gut microbiome and hypercapnia matter","volume":"57","author":"Almendros","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0321","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0322","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9343(86)90639-X","article-title":"Is atherosclerosis a complication of long-term corticosteroid treatment?","volume":"80","author":"Nashel","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0323","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.amjcard.2010.05.013","article-title":"Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm","volume":"106","author":"Achar","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0324","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC201712050","article-title":"Dyslipidemia","volume":"167","author":"Kopin","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0325","series-title":"Endotext","article-title":"Medication induced changes in lipid and lipoproteins","author":"Herink","year":"2000"},{"key":"10.1016\/j.ajpc.2022.100371_bib0326","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0327","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0328","author":"Mehta"},{"key":"10.1016\/j.ajpc.2022.100371_bib0329","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","article-title":"Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly","volume":"15","author":"Pacher","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/clc.21962","article-title":"Cannabinoids and atherosclerotic coronary heart disease","volume":"35","author":"Singla","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0331","doi-asserted-by":"crossref","first-page":"219","DOI":"10.35946\/arcr.v38.2.06","article-title":"Alcohol's effects on the cardiovascular system","volume":"38","author":"Piano","year":"2017","journal-title":"Alcohol Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0332","article-title":"Acute and chronic effects of cocaine on cardiovascular health","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2022.100371_bib0333","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","article-title":"Atherosclerosis in rheumatoid arthritis: is it all about inflammation?","volume":"11","author":"Skeoch","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0334","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/1381612825666190430113212","article-title":"Accelerated atherosclerosis in rheumatoid arthritis: mechanisms and treatment","volume":"25","author":"Reiss","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajpc.2022.100371_bib0335","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/BOR.0000000000000528","article-title":"Cardiovascular disease in systemic lupus erythematosus: an update","volume":"30","author":"Liu","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0336","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","article-title":"Psoriasis and cardiovascular risk: a comprehensive review","volume":"37","author":"Masson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.ajpc.2022.100371_bib0337","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11883-017-0692-8","article-title":"Emerging associations between neutrophils, atherosclerosis, and psoriasis","volume":"19","author":"Sanda","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0338","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5114\/reum.2019.84815","article-title":"Endothelial dysfunction in patients with ankylosing spondylitis","volume":"57","author":"\u0141osi\u0144ska","year":"2019","journal-title":"Reumatologia"},{"key":"10.1016\/j.ajpc.2022.100371_bib0339","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00296-020-04677-3","article-title":"Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study","volume":"40","author":"Dimitroulas","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ajpc.2022.100371_bib0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tcm.2019.10.001","article-title":"Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?","volume":"30","author":"Bigeh","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0341","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/ATVBAHA.121.315930","article-title":"A new small molecule increases cholesterol efflux","volume":"41","author":"Groenen","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0342","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tig.2012.03.001","article-title":"Genetics of atherosclerosis","volume":"28","author":"Lusis","year":"2012","journal-title":"Trends Genet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0343","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/thg.2018.45","article-title":"Carotid artery atherosclerosis: a review on heritability and genetics","volume":"21","author":"Forgo","year":"2018","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0344","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.115.306566","article-title":"Genetics of coronary artery disease","volume":"118","author":"McPherson","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00439-009-0654-5","article-title":"Molecular genetics of atherosclerosis","volume":"125","author":"Roy","year":"2009","journal-title":"Hum Genet"},{"key":"10.1016\/j.ajpc.2022.100371_bib0346","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12170-019-0618-9","article-title":"Lipids in South Asians: epidemiology and management","volume":"13","author":"Makshood","year":"2019","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0347","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ypmed.2016.12.017","article-title":"Cardiovascular health metrics among South Asian adults in the United States: prevalence and associations with subclinical atherosclerosis","volume":"96","author":"Talegawkar","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0348","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12170-014-0425-2","article-title":"Assessment of obesity and cardiovascular risk in South Asians","volume":"9","author":"Parikh","year":"2014","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0349","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American heart association","volume":"138","author":"Volgman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0350","article-title":"Assessment of cardiovascular disease risk in South Asian populations","volume":"2013","author":"Hussain","year":"2013","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0351","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdiacomp.2009.01.003","article-title":"Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study","volume":"24","author":"Misra","year":"2010","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.ajpc.2022.100371_bib0352","first-page":"193","article-title":"Is South Asian ethnicity an independent cardiovascular risk factor?","volume":"22","author":"Gupta","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0353","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijcard.2011.11.034","article-title":"Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: results from a multi-ethnic cohort","volume":"166","author":"Veeranna","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0354","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2369-13-37","article-title":"Association between microalbuminuria and subclinical atherosclerosis evaluated by carotid artery intima-media in elderly patients with normal renal function","volume":"13","author":"Kong","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0355","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3346\/jkms.2013.28.3.409","article-title":"Significance of microalbuminuria in relation to subclinical coronary atherosclerosis in asymptomatic nonhypertensive, nondiabetic subjects","volume":"28","author":"Park","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ajpc.2022.100371_bib0356","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5551\/jat.26260","article-title":"Impact of the serum uric acid level on subclinical atherosclerosis in middle-aged and elderly Chinese","volume":"22","author":"Chen","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ajpc.2022.100371_bib0357","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","article-title":"Hyperuricemia and endothelial function: from molecular background to clinical perspectives","volume":"278","author":"Maruhashi","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0358","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.numecd.2020.08.031","article-title":"Role of vitamin D in the pathogenesis of atheromatosis","volume":"31","author":"Rimondi","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0359","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2021.04.021","article-title":"Circulating ceramides as biomarkers of cardiovascular disease: evidence from phenotypic and genomic studies","volume":"327","author":"McGurk","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0360","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11154-021-09628-2","article-title":"Cardiovascular risk and testosterone \u2013 from subclinical atherosclerosis to lipoprotein function to heart failure","volume":"22","author":"Gencer","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ajpc.2022.100371_bib0361","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12170-018-0568-7","article-title":"The top five women's health issues in preventive cardiology","volume":"12","author":"Abouzeid","year":"2018","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0362","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12170-015-0480-3","article-title":"Primary prevention of atherosclerotic cardiovascular disease in women","volume":"10","author":"McKibben","year":"2015","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.ajpc.2022.100371_bib0363","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2021.03.005","article-title":"Managing cardiometabolic risk factors across a woman's lifespan: a lipidologist's perspective","author":"Gianos","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0364","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/STROKEAHA.113.004162","article-title":"Low socioeconomic status over 12 years and subclinical cardiovascular disease","volume":"45","author":"Thurston","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.ajpc.2022.100371_bib0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.annepidem.2019.12.009","article-title":"Discrimination, social support, and telomere length: the multi-ethnic study of atherosclerosis (MESA)","volume":"42","author":"Hailu","year":"2020","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0366","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.92.7.1786","article-title":"Socioeconomic status and carotid atherosclerosis","volume":"92","author":"Lynch","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0367","article-title":"Deintensification or no statin treatment is associated with higher mortality in patients with ischemic stroke or transient ischemic attack","author":"Dearborn-Tomazos","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.ajpc.2022.100371_bib0368","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajpc.2022.100371_bib0369","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0000000000000246","article-title":"Childhood psychosocial cumulative risks and carotid intima-media thickness in adulthood: the cardiovascular risk in young finns study","volume":"78","author":"Hakulinen","year":"2016","journal-title":"Psychosom Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0370","article-title":"Association of depression with subclinical coronary atherosclerosis: a systematic review","author":"Khan","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0371","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3389\/fimmu.2018.02031","article-title":"Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based","volume":"9","author":"Fioranelli","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0372","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00006842-199411000-00007","article-title":"Hostility and the progression of carotid atherosclerosis","volume":"56","author":"Julkunen","year":"1994","journal-title":"Psychosom Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0373","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0374","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jacc.2021.01.047","article-title":"Ultra-processed foods and incident cardiovascular disease in the framingham offspring study","volume":"77","author":"Juul","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0375","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.amjmed.2014.10.014","article-title":"The Mediterranean diet, its components, and cardiovascular disease","volume":"128","author":"Widmer","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0376","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017066","article-title":"Cardiovascular harm from egg yolk and meat: more than just cholesterol and saturated fat","volume":"10","author":"Spence","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100371_bib0377","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12937-020-00604-1","article-title":"Consumption of ultra-processed foods and health outcomes: a systematic review of epidemiological studies","volume":"19","author":"Chen","year":"2020","journal-title":"Nutr J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0378","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/CIRCRESAHA.118.314038","article-title":"Dietary fats in relation to total and cause-specific mortality in a prospective cohort of 521\u2009120 individuals with 16 years of follow-up","volume":"124","author":"Zhuang","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2022.100371_bib0379","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3945\/ajcn.115.116046","article-title":"Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease","volume":"102","author":"Guasch-Ferr\u00e9","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajpc.2022.100371_bib0380","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.11.015","article-title":"Saturated fatty acids trigger TLR4-mediated inflammatory response","volume":"244","author":"Rocha","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0381","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2021.04.010","article-title":"Extreme elevations of low-density lipoprotein cholesterol with very low carbohydrate, high fat diets","author":"Schaffer","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0382","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101398","article-title":"Implication of trimethylamine N-Oxide (TMAO) in disease: potential biomarker or new therapeutic target","volume":"10","author":"Janeiro","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpc.2022.100371_bib0383","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0384","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.119.044467","article-title":"Exercise and coronary atherosclerosis","volume":"141","author":"Aengevaeren","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0385","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.94.4.857","article-title":"Statement on exercise: benefits and recommendations for physical activity programs for all Americans","volume":"94","author":"Fletcher","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100371_bib0386","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2015.10.107","article-title":"Does sedentary lifestyle touch arterial health?","volume":"244","author":"Schmidt-Trucks\u00e4ss","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100371_bib0387","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119591","article-title":"Associations of objectively assessed physical activity and sedentary time with all-cause mortality in US adults: the NHANES study","volume":"10","author":"Schmid","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2022.100371_bib0388","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1210\/jc.2003-030398","article-title":"Hypothyroidism and atherosclerosis","volume":"88","author":"Cappola","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2022.100371_bib0389","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100371_bib0390","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamainternmed.2013.6473","article-title":"Vegetarian dietary patterns and mortality in Adventist health study 2","volume":"173","author":"Orlich","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ajpc.2022.100371_bib0391","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030817","article-title":"Vegan diet health benefits in metabolic syndrome","volume":"13","author":"Marrone","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpc.2022.100371_bib0392","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/eht426","article-title":"Are air pollution and traffic noise independently associated with atherosclerosis: the Heinz Nixdorf recall study","volume":"35","author":"K\u00e4lsch","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0393","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jacc.2017.12.015","article-title":"Environmental noise and the cardiovascular system","volume":"71","author":"M\u00fcnzel","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100371_bib0394","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehu030","article-title":"Cardiovascular effects of environmental noise exposure","volume":"35","author":"M\u00fcnzel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100371_bib0395","first-page":"245","article-title":"The cardiovascular effects of noise","volume":"116","author":"Hahad","year":"2019","journal-title":"Dtsch Arztebl Int"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667722000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667722000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:39:31Z","timestamp":1763005171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667722000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":383,"alternative-id":["S2666667722000551"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2022.100371","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2022.100371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100371"}}